DepEd/DOH Office Awardee Concentration
One supplier received at least 40% of a procuring office's PhilGEPS award value over three years.
This is a statistical anomaly or indicator worth examining — not proof of wrongdoing, fraud, or corruption against any person.
Indicator: in 2023–2025, BAJ PHARMACEUTICALS received 59.9% (₱793.13M, 7 awards) of GOVERNOR BENJAMIN T. ROMUALDEZ GENERAL HOSPITAL AND SCHISTOS's ₱1.32B in recorded PhilGEPS awards, across 326 awards and 117 suppliers. This may reflect the supplier's competitive pricing or ability to deliver a wide range of medical supplies needed by the hospital.
Only contractors and government agencies named in public procurement records are shown. Private individuals are not named.
Named in this indicator? Respond or report an error · Corrections policy
Project completion
Schedule fields from DPWH transparency portal records and the Sumbong sa Pangulo flood-control list — not inferred beyond those columns.
Completion schedule is shown for project and contractor flags only.
Rule Definition
Office must have ≥₱50M, ≥30 awards and ≥5 suppliers in the window; the supplier ≥5 awards. Severity rises at 60%.
Triggering Data & citations
In 2023–2025, BAJ PHARMACEUTICALS received 60% (₱793,131,462, 7 awards) of GOVERNOR BENJAMIN T. ROMUALDEZ GENERAL HOSPITAL AND SCHISTOS's ₱1,324,674,247 in PhilGEPS awards across 326 awards and 117 suppliers.
{
"hhi": 0.3823,
"share": 0.5987,
"supplier": "BAJ PHARMACEUTICALS",
"suppliers": 117,
"windowEnd": 2025,
"windowStart": 2023,
"officeAwards": 326,
"supplierOrgId": "f4e62144-3094-4278-88d2-4a3dfad6fc2e",
"officeValuePhp": 1324674246.8200002,
"supplierValuePhp": 793131461.54
}Source documents
Possible Innocent Explanations
- Sole distributors of specific drugs/equipment, framework agreements, or a single large construction contract can produce high shares.
- This may reflect the supplier's competitive pricing or ability to deliver a wide range of medical supplies needed by the hospital.
